Allied Biotech Dividends and Buybacks
Dividend criteria checks 4/6
Allied Biotech is a dividend paying company with a current yield of 5.03% that is well covered by earnings.
Key information
5.0%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | 7.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | NT$0.850 |
Payout ratio | 77% |
Recent dividend and buyback updates
Recent updates
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?
Apr 16These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well
Mar 05Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment
Jan 24Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?
Jan 03A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)
Dec 13Is Allied Biotech (GTSM:1780) A Risky Investment?
Nov 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1780 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 1780's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
Allied Biotech Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (1780) | 5.0% |
Market Bottom 25% (TW) | 1.7% |
Market Top 25% (TW) | 4.4% |
Industry Average (Biotechs) | 2.4% |
Analyst forecast (1780) (up to 3 years) | n/a |
Notable Dividend: 1780's dividend (5.03%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
High Dividend: 1780's dividend (5.03%) is in the top 25% of dividend payers in the TW market (4.42%)
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (77.1%), 1780's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (44.6%), 1780's dividend payments are well covered by cash flows.